Since founded in 1999, WONTECH, a global company that provides medical solutions, has been developing and producing laser and energy-based medical devices utilized across various medical fields, including aesthetic, surgical, and home devices.
Notably, “Oligio,” developed from WONTECH’s unique technology and R&D capabilities, is the company’s flagship high-frequency energy device. It has gained recognition for its technology excellence in both Korea and the global market, earning high trust due to its superior quality and performance. In addition, WONTECH has developed the Pico Brothers (Pico Alex, Pico Care Majesty, and Pico Andy), which are effective in treating pigmented lesions and skin regeneration, thereby providing a wide range of skin treatment solutions.As we move forward, WONTECH is dedicated to realizing its vision of ‘Providing solutions for the health and beauty of our customers.’

Two global leaders in the laser medical device industry have come together under the name “Cynosure Lutronic,” marking a new chapter in their journey. With an annual revenue of $500 million, Cynosure Lutronic is now the world’s largest energy-based medical device company, offering advanced technology and innovative solutions. Their products are available in over 130 countries and are trusted by medical professionals and patients alike for their cutting-edge technology, strict quality control, and tailored services. The company’s first product post-merger, the monopolar RF device ‘XERF,’ has delivered exceptional results, highlighting Cynosure Lutronic’s commitment to ongoing innovation. Moving forward, the company is poised for sustainable growth and aims to continue leading the global healthcare industry with optimal solutions.

Merz Aesthetics is a medical aesthetics company with a long history, dedicated to helping healthcare professionals, patients, and employees build confidence. Our goal is to help people worldwide look, feel, and live their best lives.
Our portfolio includes the clinically proven ultrasound lifting device ‘Ulthera®,’ botulinum toxin ‘Xeomin®,’ FDA-approved HA filler ‘Belotero®,’ and CaHA regenerative bio-stimulator ‘Radiesse®,’ ensuring safety and efficacy. Merz Aesthetics Korea focuses on quality management and raising aesthetic awareness.

Classys, a global leader in medical aesthetics, is advancing treatment technologies and is democratizing aesthetic solutions worldwide. Established in 2007 by a dermatologist, Classys is committed to providing science-backed innovations that meet the evolving needs of its customers. In 2024, following its strategic merger with Ilooda, Classys expanded its portfolio to include state-of-the-art HIFU, RF, Microneedling RF, and laser technologies. This powerful combination offers a comprehensive solution for addressing all skin care concerns, making effective treatments available for every skin type.

Dong-A ST
is a specialized pharmaceutical (ETC) company that started with Dong-A Pharmaceutical’s transition to a holding company.
We have the self-originated new drugs such as STILLEN, ZIDENA, MOTILITONE, SUGANON/SUGAMET, and market-leading drugs such as JUBLIA, TWOLION, EDARBI, and OPALMON, focused on medical devices, diagnostics and overseas business as well.?
The direction and goal of Dong-A ST is to become a global healthcare company through the development of innovative new drugs.
With the thought that Constant development of innovative drugs is for the health and happiness of mankind and fulfilling our social responsibilities, we are operating an optimal research infrastructure centered on world-class research institutes and talented individuals with outstanding capabilities.

BR PHARM specializes in regenerative medicine, focusing on the research and development of various products based on PDRN/PN raw materials. We ensures high-quality production through strict quality control processes. Committed to continuous innovation, BR Pharm strives to enhance quality of life and contribute to global health and beauty.

As the #1 medical skin care brand worldwide, the SkinCeuticals mission is to improve skin health by providing advanced skin care backed by science.
With a commitment to developing clinically-proven skincare solutions, the brand holds its formulations, clinical testing, product quality and ethics to the highest standards in order to deliver skincare solutions that benefit the health and appearance of the skin.

PharmaResearch is a leading biopharmaceutical company dedicated to R&D, sales, marketing, and production of innovative healthcare aesthetic solutions. We have pioneered the development of DOT™ technology, a unique process that extracts and refines DNA from salmon reproductive cells. DOT™ PDRN and PN, cell regeneration substances produced with the patented technology, not only promote tissue restoration but also ensure the highest standards of safety. Building on this innovation, PharmaResearch is expanding its portfolio with DOT™ PDRN-based pharmaceuticals, aesthetic medical devices, and derma cosmetics. Our flagship products include REJURAN®, a regenerative skin booster, and REJURAN® Cosmetics, a specialized skincare line for optimal skin rejuvenation. We are also developing a comprehensive pipeline for a “Total Aesthetic Solution,” featuring products like CLEVIEL, a premium hyaluronic acid filler known for its exceptional volume and lift, and Re N Tox, a trusted botulinum toxin product for wrinkle reduction and facial contouring. This positions us for our next leap in the anti-aging market.